Prescription for Change: Policy Recommendations for Women’s Health Research
Women’s health is under-researched, underfunded and under-represented. The implications are far-reaching, influencing diagnosis, treatments and ultimately health outcomes for women. Addressing the women’s health research gap is not only an ethical imperative but also a critical step towards more robust science and better health outcomes for all.
Women’s health is under-researched, underfunded and under-represented. The implications are far-reaching, influencing diagnosis, treatments and ultimately health outcomes for women. Addressing the women’s health research gap is not only an ethical imperative but also a critical step towards more robust science and better health outcomes for all.
Prescription for Change: Policy Recommendations to Protect and Promote Women’s Health was developed as a collaboration between the Global Alliance for Women’s Health and more than 45 organizations from industry, regulators and beyond, working jointly to transform the policy landscape in women’s health science and innovation. This comprehensive white paper addresses the critical gaps in women’s health research and proposes actionable policy recommendations to drive innovation, expand inclusion in clinical trials, enhance data disaggregation, design clinical trials with women in mind and deepen sex-specific insights. In doing so, the aim is to create a more supportive environment for women’s health science and innovation and improve health outcomes for women, transforming global health outcomes and, in doing so, unlocking significant economic benefits.